Search Filters

  • Media Source
  • Presentation Format
  • Media Type
  • Media Year
  • Language
  • Diagnosis / Condition
  • Diagnosis Method
  • Patient Populations
  • Treatment / Technique

Preoperative Opioid Use is Associated with Worse Baseline Measures in Hip Arthroscopy Patients

Preoperative Opioid Use is Associated with Worse Baseline Measures in Hip Arthroscopy Patients

Michael Rocca, MD, UNITED STATES Evan L. Honig, MD, UNITED STATES Andrew Tran, MD, UNITED STATES Matthew Kolevar, MD, UNITED STATES Samir Kaveeshwar, MD, UNITED STATES Ali Aneizi, MD, UNITED STATES Natalie Luanne Leong, MD, UNITED STATES Jonathan D. Packer, MD, UNITED STATES R Frank Henn, MD, UNITED STATES Sean J. Meredith, MD, UNITED STATES

University of Maryland , Baltimore, Maryland, UNITED STATES


2023 Congress   ePoster Presentation   2023 Congress   Not yet rated

 

Anatomic Location

Anatomic Structure

Diagnosis / Condition

Treatment / Technique


Summary: Nearly 20% of hip arthroscopy patients were taking opioid medications prior to surgery and those patients taking opioids preoperatively had significantly worse baseline physical function, pain, social satisfaction, and depression than those who did not use preoperative opioids.


Introduction

As hip arthroscopy has dramatically grown in recent years, it is increasingly important to utilize patient reported outcomes (PROs) to help guide clinical practice. Despite the growing literature on hip arthroscopy, there is limited literature on the association between PROs in hip arthroscopy and preoperative opioid usage. The purpose of this study was to evaluate the rate of preoperative opioid usage and its association with preoperative PROs.

Methods

A single institution orthopaedic registry was retrospectively analyzed. All patients undergoing hip arthroscopy from 2015 to 2022 were analyzed. Patients were administered the Patient-Reported Outcomes Measurement Information System (PROMIS) in six domains, Numeric Pain Scores, and Musculoskeletal Outcomes Data Evaluation and Management System (MODEMS) Expectations domain preoperatively. Patients’ charts were reviewed to determine demographic factors and preoperative opioid use within 6 weeks of surgery. Bivariate analysis was used to determine associations between preoperative opioid use and baseline PROs. Significant bivariate associations were further tested by multivariate analysis to determine independent predictors.

Results

Of the 123 patients included in the study, 21 patients (17%) were taking opioid mediations preoperatively. Prior orthopaedic or other surgeries were significantly associated with preoperative opioid use, but prior hip surgery was not associated. Patients with preoperative opioid use scored significantly worse on preoperative PROMIS Physical Function (PF; 38.6±4.9 versus 40.5±6.9; p = 0.011), Pain Interference (PI; 65.9±8.0 versus 60.2±6.1; p = 0.001), Fatigue (60.7±12.4 versus 51.6±10.1; p = 0.005), Social Satisfaction (SS; 38.2±7.6 versus 43.2±7.5; p = 0.007), and Depression (54.2±11.0 versus 48.8±9.0; p = 0.012) compared to those without preoperative opioid use. Preoperative opioid use was also associated with significantly worse Numeric Pain Scores for both the operative hip (6.3±2.4 versus 4.6±2.3; p = 0.003) and whole body (3.0±2.7 versus 1.4±2.0; p = 0.008). On multivariate analysis, preoperative opioid use was an independent predictor of worse baseline PROMIS PI, Fatigue and SS scores and Numeric Pain Score for the operative hip.

Conclusion

Hip arthroscopy patients with preoperative opioid use had significantly worse baseline PROs for physical function, pain, social satisfaction, and depression than those who did not use preoperative opioids. When controlling for confounding variables, preoperative opioid use was predictive of worse baseline pain, fatigue and social satisfaction. Preoperative opioid use should be recognized prior to surgery and its effects on baseline measures should be considered.


More 2023 ISAKOS Congress Content